Alkermes Plc (ALKS)

Oct 07, 2025

Do Options Traders Know Something About Alkermes Stock We Don't? - Yahoo Finance

Oct 07, 2025

Oct 07, 2025

Robeco Institutional Asset Management B.V. Buys 36,467 Shares of Alkermes plc $ALKS - MarketBeat

Oct 07, 2025

Oct 06, 2025

Substance Abuse Treatment Market Size, Growth Analysis 2031 - openPR.com

Oct 06, 2025

Oct 06, 2025

Is Alkermes plc (8AK) stock at risk of policy regulationGold Moves & Daily Entry Point Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Is Alkermes plc reversing from oversold territoryTrade Risk Assessment & Reliable Breakout Stock Forecasts - newser.com

Oct 06, 2025

Oct 05, 2025

Is Alkermes plc (8AK) stock cheap vs fundamentalsWeekly Trading Summary & AI Optimized Trade Strategies - newser.com

Oct 05, 2025

Oct 05, 2025

Will Alkermes plc (8AK) stock hit Wall Street targetsVolume Spike & Comprehensive Market Scan Insights - newser.com

Oct 05, 2025

Oct 05, 2025

Technical analysis overview for Alkermes plc stockMarket Weekly Review & Fast Exit/Entry Strategy Plans - newser.com

Oct 05, 2025

Oct 04, 2025

Alkermes Plc Experiences Evaluation Revision Amidst Mixed Market Signals and Performance Trends - Markets Mojo

Oct 04, 2025

Oct 03, 2025

Alkermes sued over alleged scheme to block generic Vivitrol - Reuters

Oct 03, 2025

Oct 03, 2025

Is Alkermes plc a good long term investmentMACD Trading Signals & Investor Community Interactions - earlytimes.in

Oct 03, 2025

Oct 03, 2025

Will Alkermes plc (8AK) stock benefit from Fed rate cuts2025 Market Overview & Comprehensive Market Scan Insights - newser.com

Oct 03, 2025

Oct 03, 2025

Can Alkermes plc stock deliver strong Q4 earningsPortfolio Growth Summary & Fast Gaining Stock Reports - newser.com

Oct 03, 2025

Oct 03, 2025

How cyclical is Alkermes plc (8AK) stock compared to rivals2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - newser.com

Oct 03, 2025

Oct 03, 2025

What candlestick patterns are forming on Alkermes plcJuly 2025 Patterns & Fast Gain Stock Trading Tips - newser.com

Oct 03, 2025

Oct 01, 2025

Alkermes Plc Hits Day High with Strong 10.58% Intraday Surge - Markets Mojo

Oct 01, 2025

Oct 01, 2025

Alkermes (ALKS) Added to Wells Fargo's Tactical Ideas List - GuruFocus

Oct 01, 2025

Sep 30, 2025

What analysts say about Alkermes plc 8AK stockPrice-to-Earnings Ratio Insights & Budget Friendly Capital Growth - earlytimes.in

Sep 30, 2025

Sep 30, 2025

What drives Alkermes plc stock priceMarket Breadth Indicators & Explosive Profit Trading - earlytimes.in

Sep 30, 2025

Sep 29, 2025

Alkermes : Corporate Responsability Report - MarketScreener

Sep 29, 2025

Sep 29, 2025

Alkermes plc (ALKS) Stock Analysis: Exploring a 49.54% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Sep 29, 2025

Sep 29, 2025

U.S. Buprenorphine Market Set for Dynamic Growth with Key - openPR.com

Sep 29, 2025

Sep 28, 2025

How Investors May Respond To Alkermes (ALKS) Phase 2 Alixorexton Narcolepsy Trial Outperformance - Sahm

Sep 28, 2025

Sep 28, 2025

Alkermes upgraded at RBC Capital Markets ahead of key catalyst - MSN

Sep 28, 2025

Sep 28, 2025

Is Alkermes' (ALKS) Narcolepsy Drug Breakthrough Shifting Its Investment Narrative? - Yahoo Finance

Sep 28, 2025

Sep 26, 2025

Alkermes Plc Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo

Sep 26, 2025

Sep 26, 2025

Alkermes' Stock Dip on Narcolepsy Data Seen as Buying Opportunity, RBC Says - MarketScreener

Sep 26, 2025

Sep 26, 2025

Alkermes stock upgraded at RBC Capital Markets (ALKS:NASDAQ) - Seeking Alpha

Sep 26, 2025

Sep 26, 2025

Alkermes (NASDAQ:ALKS) Shares Gap Up After Analyst Upgrade - MarketBeat

Sep 26, 2025

Sep 26, 2025

Alkermes (NASDAQ:ALKS) Upgraded by Royal Bank Of Canada to "Outperform" Rating - MarketBeat

Sep 26, 2025

Sep 26, 2025

RBC Capital Upgrades ALKS: Price Target Raised to $44 | ALKS Sto - GuruFocus

Sep 26, 2025